A 133 (see companion bill S 1737) – New York
Introduced: 2021 Status: In Process
Creates a wholesale prescription drug importation program which complies with federal standards and regulations for the purpose of generating substantial savings for consumers.
A 2681 (see companion bill S 1732) – New Jersey
Introduced: 2020 Status: Inactive / Dead
Permits import of Canadian prescription drugs.
A 2809 – New Jersey
Introduced: 2022 Status: In Process
Permits import of Canadian prescription drugs.
A 5947 – New Jersey
Introduced: 2019 Status: Inactive / Dead
Permits import of Canadian prescription drugs.
A 5947 – New Jersey
Introduced: 2019 Status: Inactive / Dead
Permits import of Canadian prescription drugs.
A 9553 – New York
Introduced: 2018 Status: Inactive / Dead
PRESCRIPTION DRUG REIMPORTATION PROTECTION PROGRAM. Provides for the prescription drug reimportation protection program to be established by the superintendent of state police, for the investigation of the sale of unsafe drugs including internet sales.
AB 458 – California
Introduced: 2021 Status: Inactive / Dead
Importation of prescription drugs. Existing law establishes the California Health and Human Services Agency (CHHSA), which includes departments charged with the administration of health, social, and other human services. Existing law requires CHHSA to enter …
AB 548 (see companion bill SB 539) – Wisconsin
Introduced: 2021 Status: Inactive / Dead
This bill requires the commissioner of insurance, in consultation with persons interested in the sale and pricing of prescription drugs and federal officials and agencies, to design and implement a prescription drug importation program for …
AB 748 (see companion bill SB 719) – Wisconsin
Introduced: 2023 Status: In Process
Cost-sharing cap on insulin This bill prohibits every health insurance policy and governmental self-insured health plan that cover insulin and impose cost sharing on prescription drugs from imposing cost sharing on insulin in an amount …
D.C. Code § 48-831.04. Cost containment and savings with respect to existing publicly funded pharmaceutical programs: Affordability of Prescription Drugs- AccessRx Program – District of Columbia
Status: Enacted Year Enacted: 2004
The Department shall make every effort to reduce and contain the cost of prescription drugs purchased for publicly funded pharmaceutical assistance programs, including D.C. Medicaid, the D.C. Health Care Alliance, and the Department of Mental …
Download
H 2377 – Massachusetts
Introduced: 2021 Status: Inactive / Dead
Relative to the wholesale importation of prescription drugs into the Commonwealth. Public Health.
HB 1005 – Indiana
Introduced: 2020 Status: Inactive / Dead
Health and insurance matters. Establishes the importation of prescription drugs program (program) for the importation of prescription drugs to be administered by the state department of health (state department). Requires the state department to apply …
HB 1022 – Tennessee
Introduced: 2021 Status: Inactive / Dead
As introduced, enacts the “Safe, Low-Cost Prescription Drugs Program Act.” – Amends TCA Title 4; Title 53; Title 68 and Title 71. This bill requires the department of health, in consultation with interested stakeholders and …
HB 1228 – Indiana
Introduced: 2019 Status: Inactive / Dead
Prescription drug importation study. Requires the state department of health to conduct a study and report to the legislative council concerning a state prescription drug importation program through which the state would import certain prescription …
Download
HB 1257 – Missouri
Introduced: 2021 Status: Inactive / Dead
Requires the department of health and senior services to develop and implement a wholesale prescription drug importation program. This bill authorizes the Department of Health and Senior Services to develop by January 1, 2022, a …
HB 1280 – New Hampshire
Introduced: 2019 Status: Enacted
Relative to copayments for insulin, establishing a wholesale prescription drug importation program, establishing a New Hampshire prescription drug affordability board, establishing the prescription drug competitive marketplace, relative to the pricing of generic prescription drugs, relative …